- Home
- GHRS
GHRS
GH Research PLC
as 07-26-2024 4:00pm EST
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders. The company is focused on developing novel and proprietary Mebufotenin 5-Methoxy-N, N-Dimethyltryptamine, or 5-MeO-DMT, therapies for the treatment of patients with Treatment-Resistant Depression, or TRD.
| Founded: | 2018 | Country: | Ireland |
| Employees: | N/A | City: | N/A |
| Market Cap: | 596.2M | IPO Year: | 2021 |
| Target Price: | $36.67 | AVG Volume (30 days): | 35.1K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.62 | EPS Growth: | N/A |
| 52 Week Low/High: | $5.05 - $14.99 | Next Earning Date: | 08-21-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest GH Research PLC News
GHRS Breaking Stock News: Dive into GHRS Ticker-Specific Updates for Smart Investing
Simply Wall St.
2 months ago
GH Research (NASDAQ:GHRS) Is In A Good Position To Deliver On Growth Plans
Zacks
2 months ago
Recent Price Trend in GH Research (GHRS) is Your Friend, Here's Why
Zacks
3 months ago
Wall Street Analysts Predict a 166.89% Upside in GH Research (GHRS): Here's What You Should Know
GlobeNewswire
3 months ago
GH Research Reports First Quarter 2024 Financial Results and Provides Business Updates
Zacks
5 months ago
How Much Upside is Left in GH Research PLC (GHRS)? Wall Street Analysts Think 321.28%
GlobeNewswire
5 months ago
GH Research Reports Full Year 2023 Financial Results and Provides Business Updates
Benzinga
6 months ago
I Want To Add An Investment Property To My Retirement Portfolio. Should I Focus On Cash Flow Or Appreciation?
Insider Monkey
6 months ago
Bridgewater Bancshares, Inc. (NASDAQ:BWB) Q4 2023 Earnings Call Transcript
Compare GHRS vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "GHRS GH Research PLC - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.